Clinical Trial: A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Prostate Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Randomized, Open-Label, Dose-Finding Study of Debio 4228, an Extended-Release Formulation of Gonadotropin-Releasing Hormone Antagonist in Participants With Advanced Prostate Cancer
Brief Summary:
The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.
Read more